Link Pharma Chem Limited (BOM:524748)
27.00
-1.00 (-3.57%)
At close: Jun 1, 2026
Link Pharma Chem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 6.34 | 0.65 | 0.64 | 0.94 | 2.68 |
Cash & Short-Term Investments | 6.34 | 0.65 | 0.64 | 0.94 | 2.68 |
Cash Growth | 882.33% | 0.47% | -31.63% | -64.95% | -94.48% |
Accounts Receivable | 52.8 | 50.17 | 51.52 | 36.3 | 53.65 |
Other Receivables | - | - | - | 0.18 | 0.53 |
Receivables | 53 | 50.26 | 51.64 | 37.2 | 54.59 |
Inventory | 50.23 | 57.37 | 62.08 | 122.5 | 47.57 |
Prepaid Expenses | - | 0.64 | 0.64 | 0.47 | 0.72 |
Other Current Assets | 3.84 | 2.68 | 0.26 | 14.39 | 30.15 |
Total Current Assets | 113.4 | 111.59 | 115.26 | 175.49 | 135.72 |
Property, Plant & Equipment | 103.77 | 92.77 | 99.37 | 90.03 | 89.97 |
Long-Term Investments | 24.73 | 20.55 | 29.33 | 36.39 | 45.19 |
Long-Term Deferred Tax Assets | 1.57 | 2.32 | - | - | - |
Other Long-Term Assets | 6.14 | 5.69 | 15.54 | 22.67 | 18.77 |
Total Assets | 249.62 | 232.93 | 259.5 | 324.58 | 289.64 |
Accounts Payable | 32.55 | 34.83 | 17.58 | 66.07 | 45.28 |
Accrued Expenses | - | 11.58 | 10.64 | 9.24 | 23.91 |
Short-Term Debt | - | 51.23 | 78.18 | 57.89 | 25.84 |
Current Portion of Long-Term Debt | 66.09 | 2.42 | 3.46 | 9.88 | 9.02 |
Current Income Taxes Payable | - | - | - | 1.45 | 1.37 |
Other Current Liabilities | 13.78 | 0.46 | 0.19 | 0.62 | 0.71 |
Total Current Liabilities | 112.42 | 100.52 | 110.05 | 145.15 | 106.13 |
Long-Term Debt | 6.95 | 4.17 | 10.58 | 19.8 | 29.02 |
Pension & Post-Retirement Benefits | 2.36 | 1.62 | 0.02 | 2.02 | 0.35 |
Long-Term Deferred Tax Liabilities | - | - | 1.76 | 7.23 | 9.41 |
Other Long-Term Liabilities | - | - | - | -0 | - |
Total Liabilities | 121.73 | 106.31 | 122.42 | 174.19 | 144.89 |
Common Stock | 44.41 | 44.41 | 44.41 | 44.41 | 44.41 |
Additional Paid-In Capital | - | 28.71 | 28.71 | 28.71 | 28.71 |
Retained Earnings | - | 53.39 | 63.85 | 77.19 | 71.54 |
Comprehensive Income & Other | 83.49 | 0.11 | 0.12 | 0.09 | 0.09 |
Shareholders' Equity | 127.89 | 126.62 | 137.09 | 150.39 | 144.75 |
Total Liabilities & Equity | 249.62 | 232.93 | 259.5 | 324.58 | 289.64 |
Total Debt | 73.04 | 57.82 | 92.22 | 87.57 | 63.88 |
Net Cash (Debt) | -66.71 | -57.18 | -91.58 | -86.63 | -61.2 |
Net Cash Per Share | -14.75 | -12.88 | -20.62 | -19.51 | -13.78 |
Filing Date Shares Outstanding | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
Total Common Shares Outstanding | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
Working Capital | 0.99 | 11.07 | 5.21 | 30.35 | 29.59 |
Book Value Per Share | 28.80 | 28.51 | 30.87 | 33.87 | 32.60 |
Tangible Book Value | 127.89 | 126.62 | 137.09 | 150.39 | 144.75 |
Tangible Book Value Per Share | 28.80 | 28.51 | 30.87 | 33.87 | 32.60 |
Land | - | 16.15 | 16.15 | 2.27 | 2.27 |
Buildings | - | 25.84 | 25.84 | 26.32 | 19.57 |
Machinery | - | 117.49 | 114.66 | 110.2 | 105.54 |
Construction In Progress | - | - | - | - | 2.11 |